Rapid Micro Q2 Revenue Climbs 11%, Gross Margin Reaches 15%, but Cash Burn Accelerates; Workforce Cuts Announced
RPID sits 25% above its 52-week low of $1.66.
Summary
Rapid Micro Biosystems posted 11% revenue growth and a record 15% gross margin in Q2 2026, but cash burn accelerated and cash reserves fell to $14.7 million. A post-quarter workforce reduction aims to save $3 million in 2027, while the CEO adopted a new 10b5-1 plan to sell up to 396,828 shares.
Key Events · Earnings and Guidance · RPID
-
Q2 Revenue Up 11%, Gross Margin Improves
Revenue reached $8.1 million, driven by higher consumable sales and system placements. Gross margin expanded to 15.0% from 3.8% a year ago, reflecting lower service costs and improved product margins.
-
Net Loss Widens, Cash Burn Accelerates
Net loss was $12.9 million vs. $11.9 million in Q2 2025. Operating cash outflow was $27.8 million in H1 2026, up from $18.8 million a year earlier, driven by working capital changes and higher personnel costs.
-
Cash Reserves Dwindle to $14.7 Million
Cash and equivalents fell to $14.7 million from $20.0 million at year-end 2025, despite $9.6 million in financing proceeds from the May 2026 offering. The company expects existing resources plus potential debt tranches to fund operations for at least 12 months.
-
Post-Quarter Workforce Reduction Announced
In August 2026, the company implemented cost actions including workforce reductions, expecting to save approximately $3 million in 2027 and $1 million in the remainder of 2026, with a $0.4 million charge in Q3 2026.
Analysis · RPID · Industrial Applications And Services
Rapid Micro Biosystems delivered Q2 2026 revenue of $8.1 million, an 11% year-over-year increase, while gross margin jumped to 15% from 3.8% a year ago. Yet the net loss widened to $12.9 million, and cash used in operations surged to $27.8 million in the first half, leaving just $14.7 million in cash and equivalents. In a post-quarter move signaling urgent cost control, the company disclosed a workforce reduction expected to save roughly $3 million in 2027. Adding potential selling pressure, the CEO adopted a new 10b5-1 trading plan for up to 396,828 shares. Despite improving gross margins, the combination of accelerating cash burn, a shrinking cash cushion, and a restructuring underscores the company's fragile financial position.
At the time of this filing, RPID was trading at $2.08 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $103.6M. The 52-week trading range was $1.66 to $4.94. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.